• Users Online: 420
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2019  |  Volume : 7  |  Issue : 2  |  Page : 63-65

Successful treatment of bronchorrhea with gefitinib in a patient with bronchioloalveolar cell lung carcinoma

1 Department of Respiratory Medicine, Medical College, Kolkata, India
2 Department of Pediatric Medicine, Calcutta National Medical College, Kolkata, India
3 Department of Respiratory Medicine, Murshidabad Medical College, Murshidabad, West Bengal, India

Correspondence Address:
Sibes Kumar Das
Souhardya Appartment, West BankimPally, Madhyamgram, Kolkata - 700129
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jacp.jacp_3_19

Rights and Permissions

Bronchorrhea is defined as production of more than 100 mL watery sputum per day. Although found in several diseases and disorders, it is classically described in bronchioloalveolar cell lung carcinoma. It hampers the quality of life of the patient with lung cancer. Several treatment options are available for relief of this distressing symptom; however, none of them are effective in all cases. We herein report a case of a female with bronchioloalveolar cell lung carcinoma who presented with bronchorrhea. She showed dramatic symptomatic improvement with therapy with gefitinib.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded353    
    Comments [Add]    

Recommend this journal